Cleared Traditional

K883002 - QM300 PREALBUMIN ANTIBODY PACK

K883002 is the FDA 510(k) clearance for QM300 PREALBUMIN ANTIBODY PACK by Kallestad Diag, A Div. of Erbamont, Inc.. It is a Class 1 Immunology device (product code JZJ) cleared through the Traditional 510(k) pathway after a 66-day FDA review.

K883002 · Kallestad Diag, A Div. of Erbamont, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1988
Decision
66d
Days
Class 1
Risk

K883002 is an FDA 510(k) clearance for the QM300 PREALBUMIN ANTIBODY PACK. Classified as Prealbumin, Antigen, Antiserum, Control (product code JZJ), Class I - General Controls.

Submitted by Kallestad Diag, A Div. of Erbamont, Inc. (Chaska, US). The FDA issued a Cleared decision on September 22, 1988 after a review of 66 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5060 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Kallestad Diag, A Div. of Erbamont, Inc. devices

Submission Details

510(k) Number K883002 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 1988
Decision Date September 22, 1988
Days to Decision 66 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 104d · This submission: 66d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JZJ Prealbumin, Antigen, Antiserum, Control
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.5060
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JZJ Prealbumin, Antigen, Antiserum, Control

All 8
Devices cleared under the same product code (JZJ) and FDA review panel - the closest regulatory comparables to K883002.
TINA-QUANT PREALBUMIN
K972638 · Boehringer Mannheim Corp. · Jan 1998
HUMAN PREALBUMIN RADIAL IMMUNODIFFUSION KIT
K951966 · Kent Laboratories, Inc. · Jun 1995
PREALBUMIN IMMUNOLOGICAL NL TEST KIT
K913672 · The Binding Site, Ltd. · Dec 1991
ANTISERUM TO HUMAN PREALBUMIN
K850686 · Kent Laboratories, Inc. · Nov 1985
LASER PREALBUMIN TEST
K851912 · Behring Diagnostics, Inc. · Jun 1985
PREALBUMIN ENZYME IMMUNOASSAY
K821135 · Abbott Laboratories · May 1983